WILLIAM K HEIDEN Insider Trading
Get free email notifications about insider trading for WILLIAM K HEIDEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM K HEIDEN. WILLIAM K HEIDEN is a CEO in AMAG PHARMACEUTICALS INC. ($AVM) and a President & CEO in AMAG PHARMACEUTICALS INC. ($AVM) and a President and CEO in AMAG PHARMACEUTICALS INC. ($AVM) and a President & COO in PRAECIS PHARMACEUTICALS INC ($PRCS) and a President and COO in PRAECIS PHARMACEUTICALS INC ($PRCS) and a Director in Atara Biotherapeutics, Inc. ($ATRA).
Address: C/O PRAECIS PHARMACEUTICALS 830 WINTER STREET WALTHAM 02451 MA
Companies in which WILLIAM K HEIDEN is an Insider
AMAG PHARMACEUTICALS, INC.
Trading Symbol: AVMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM K HEIDEN: President & CEO, President and CEO
Holdings: 424,612 shares
Latest Transaction: Mar 04 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Atara Biotherapeutics, Inc.
Trading Symbol: ATRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of WILLIAM K HEIDEN: Director
Holdings: 20,500 shares
Current Value: $308,525
Latest Transaction: Jun 17 2020
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PRAECIS PHARMACEUTICALS INC
Trading Symbol: PRCSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM K HEIDEN: President and COO, President & COO
Holdings: 22,000 shares
Latest Transaction: Jan 16 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of WILLIAM K HEIDEN
Sentiment: All, AVM, ATRA, PRCS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2020 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Option Exercise | A | 10.54 | 24,500 | 258,230 | 24,500 | |
Jun 17 2020 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Grant | A | 0.00 | 8,000 | 0 | 20,500 | 12.5 K to 20.5 K (+64.00 %) |
Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 7.75 | 4,451 | 34,495 | 424,612 | 429.1 K to 424.6 K (-1.04 %) |
May 09 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Buy | P | 10.70 | 10,000 | 107,000 | 490,056 | 480.1 K to 490.1 K (+2.08 %) |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Option Exercise | A | 15.51 | 70,000 | 1,085,700 | 70,000 | |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 132,000 | 0 | 488,058 | 356.1 K to 488.1 K (+37.07 %) |
Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 31,000 | 0 | 356,058 | 325.1 K to 356.1 K (+9.54 %) |